Skip to main content
. Author manuscript; available in PMC: 2019 Jul 26.
Published in final edited form as: J Med Chem. 2018 Jul 17;61(14):6110–6120. doi: 10.1021/acs.jmedchem.8b00483

Figure 5.

Figure 5.

Antitumor efficacy of 28 (CF53) and 3 (OTX015) in the MDA-MB-231 xenograft model in SCID mice. These compounds were administered via oral gavage at indicated dose-schedules. (A). Tumor growth inhibition. (B). Percentage of animal weight change.